UKD Ajith Goonetilleke

Dr. UKD Ajith Goonetilleke Consultant Neurologist


Years of Experience : 25

Nationality : United Kingdom

Languages Known : English

Biography

Dr. Ajith received his medical degree from St. Thomas’s Hospital Medical School in London, United Kingdom (UK). He has a vast experience in training and working in several eminent neurosciences’ centers, including the Institute of Neurology and the National Hospital for Neurology and Neurosurgery in London, Charing Cross and Westminster Hospitals in London, Newcastle, Manchester, and Edinburgh. He was a Consultant and Senior Lecturer in Neurology in Newcastle (UK) for 11 years, before moving to work at Mafraq Hospital in the United Arab Emirates (UAE) in 2009. At Mafraq Hospital Dr. Ajith was the Chief of Neurology Department from 2009 till 2019. He was the Chair of the Pharmacy and Therapeutics Committee, and the Chair of Medicine, from 2010 till 2019. Dr. Ajith was the longest standing Chair of Medicine in SEHA in recent times. In 2009 he established the first 24/7 intravenous thrombolysis service for acute ischemic stroke in the Emirate of Abu Dhabi. In 2019 Dr. Ajith was solely responsible from moving the Neurology and Neurophysiology Departments from Mafraq Hospital to Sheikh Shakhbout Medical City (SSMC), a new 760-bedded hospital jointly operated by Mayo Clinic (US) and SEHA (Government Healthcare Provider in UAE). At SSMC he was the Chief of Neurology and Chair of the SSMC Pharmacy and Therapeutics Committee. In July 2013 Dr. Ajith was selected as the first Chair of the SEHA Pharmacy and Therapeutics Committee and continued in this role until he left SEHA in August 2021. In July 2019 Dr. Ajith was selected as the first Physician Lead in the SEHA Ethics and Compliance Committee. Dr. Ajith is an Associate Professor for the Gulf Medical University (UAE), and an Adjunct Clinical Professor for the Khalifa University College of Medicine & Health Sciences (UAE).

Dr. Ajith has published numerous articles and chapters in international peer-reviewed journals and books and presented in numerous national and international conferences. In 2016, he organized the first Neuro-degenerative Disorders Forum in Abu Dhabi, which has subsequently become established as a popular and successful annual event. Besides being an eminent Clinical Neurologist, Dr. Ajith has an extensive experience in clinical leadership and managerial roles. He also has an academic background in leadership and management. In 2017 the Royal College of Physicians and Birkbeck College (University of London) jointly awarded Dr. Ajith a Postgraduate Diploma in Medical Leadership (Merit grade). In November 2019 he completed his MBA Essentials Course with the London School of Economics and Political Science. He is currently studying for a full time MBA with the University of Durham, having been awarded the prestigious Durham University Business School Achievement Scholarship.

Awards & Achievements

  • Certificate of Specialist Training in Neurology, UK
  • The Specialist Training Authority of the Medical Royal Colleges, UK
  • PG Dip (Medical Leadership), Merit Grade, University of London
  • Full-time MBA Program at Durham University, UK (Business School with a Triple Accreditation by AMBA, AACSB, and Eques)
  • February 1992 - Gordon Holmes Registrar's Prize Royal Society of Medicine, Section of Neurology, UK
  • March 1994 - Norman Plummer Prize Clinical Postgraduate Prize, Charing Cross Hospital, UK
  • December 2010 - Best Clinical Research Award Second SEHA Research Conference, Abu Dhabi, UAE
  • December 2010 - Most Read of CME Articles by Neurologists in 2010, and 2nd Most E-mailed Article on Medscape in 2010 Medscape Online Continuing Medical Education
  • November 2017 - PG Diploma (Medical Leadership), Merit Grade for a Postgraduate Diploma in Medical Leadership (Joint Approval by the Royal College of Physicians, and Birkbeck College, University of London)
  • April 2021 - Durham University Business School Achievement Scholarship
  • May 2021 - Awarded a UAE Golden Visa as a Special Talent

Research & Publications

  • Goonetilleke A. The direction of scratch test. J Neurol Neurosurg Psychiatry 1993; 56:578
  • Goonetilleke A, Guiloff RJ. Accuracy, reproducibility, and variability of quantitative assessments of bulbar and respiratory function on motor neuron disease (MND). J Neurol Neurosurg Psychiatry 1993; 56:729
  • Goonetilleke A, Guiloff RJ. Accuracy, reproducibility, and variability of hand-held dynamometry in motor neuron disease (MND). J Neurol Neurosurg Psychiatry 1993; 56:729
  • Goonetilleke A, Guiloff RJ. Longitudinal assessments in motor neuron disease (MND)- implications for therapeutic trials. Can J Neurol Sci 1993;20(suppl.4): S81
  • Goonetilleke A, Modarres-Sadeghi H, Guiloff RJ. Accuracy, reproducibility, and variability of hand-held dynamometry in motor neuron disease. J Neurol Neurosurg Psychiatry 1994; 57:326-32
  • Goonetilleke A, Guiloff RJ. Accuracy, reproducibility, and variability of quantitative assessments of bulbar and respiratory function on motor neuron disease. J Neurol Sci 1994;124 (suppl): 64-6
  • Goonetilleke A. Ten questions answered: motor neuron disease- GP's role with patients and their careers. Pulse 1994; 54:72-80
  • Goonetilleke A, Guiloff RJ. Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368). J Neurol Neurosurg Psychiatry 1995; 58:201-8
  • Goonetilleke A. Neurology symposium: current therapies in motor neuron disease. BJHM 1995;53(7):314-7
  • Goonetilleke A. Validity of the London handicap scale. J Neurol Neurosurg Psychiatry 1995; 58:125-126
  • Goonetilleke A. Symptomatic carotid lesions in young adults. BMJ 1995; 311:1436
  • Goonetilleke A, Yuill GM. Aberrant regeneration of the third cranial nerve. J Neurol Neurosurg Psychiatry 1996; 60:281
  • Guiloff RJ, Goonetilleke A, Emami J. Riluzole and amyotrophic lateral sclerosis. Lancet 1996; 348:336-7
  • Fenwick S, Goonetilleke A, Santosh CG, Newman PK. Cerebral venous thrombosis in Bechet’s disease. J Neurol Neurosurg Psychiatry 1997; 63:419
  • Goonetilleke A, Nikhar N, Tan SV, Orrell RW, Guiloff RJ. Clinical assessment of muscle force. J Neurol Neurosurg Psychiatry 1997; 62:213
  • Macleod MA, Goonetilleke A, Fisher C, Newman PK. Isolated myoclonus of platysma. J Neurol Neurosurg Psychiatry 1997; 62:214
  • Goonetilleke A, Nikhar N, Tan SV, Orrell RW, Guiloff RJ. Assessing human muscle force. J Neurol Sci 1997;150 (suppl): S4
  • Vaidya B, Coulthard A, Goonetilleke A, Burn DJ, James RA, Kendall-Taylor P. Cerebral venous sinus thrombosis-a late sequel of invasive fibrous thyroiditis. Thyroid 1998;8(9):787-90
  • Goonetilleke A. Peripheral nerve disorders. Surgery 2001: 185-190
  • Goonetilleke A, Harris JB. Envenomation, and consumption of poisonous seafood. J Neurol Neurosurg Psychiatry 2002; 73:103-109
  • Goonetilleke A, Harris JB. Clostridial neurotoxins. J Neurol Neurosurg Psychiatry 2004;75 (Suppl III):40-46
  • Goonetilleke A, Harris JB. Animal poisons and the nervous system: what the neurologist needs to know. J Neurol Neurosurg Psychiatry 2004;75 (Suppl III):35-39
  • Birchall D, Mitra D, Chinnery P, Goonetilleke A, Bushby K. Use of MR imaging for the phenotypic characterization of muscular dystrophy. Australasian Radiology 2004;48(2): A18
  • Mahad DJ, Baker M, Thomas L, Goonetilleke A, Walls TJ, Perry R, Reid M. Immunotyping of the cerebrospinal fluid lymphocytes by flow cytometry in primary central nervous system B-cell lymphoma. Immunology: Annual Congress of the British Society for Immunology 2005
  • Jaiser SR, Cassidy A, Guadagno JV, Schaefer AM, Anderson K, Goonetilleke A. Denture cream as a cause of copper deficiency and neurological disease. J Neurol Neurosurg Psychiatry 2009; 80(11): e3
  • Goonetilleke A. A 34-year-old female with acute dizziness, hiccups, poor coordination, and sensory disturbance of the limbs. Published online in October 2010 as CME Case of the Week (Medscape). This article was rated the Number 1 Most-Read of Medscape CME articles by Neurologists in 2010 as well as Number 2 Most E-mailed Article on Medscape in 2010
  • Goonetilleke A. The importance of early treatment in multiple sclerosis. Make Sense Newsletter, April 2013
  • Goonetilleke A. Brain on fire. J Clin Case Rep, 2016
  • Goonetilleke A, de Belleroche J, Guiloff RJ. Motor Neuron Disease. In Tipton KF, ed. Essays in Biochemistry. London: Portland Press Limited, 1994:27-45
  • Guiloff RJ, Goonetilleke A. Longitudinal clinical assessments in motor neuron disease: relevance to clinical trials. In Clifford Rose F, ed. ALS- from Charcot to the present and into the future. London: Smith-Gordon Publications, 1994:73-82
  • Guiloff RJ, Goonetilleke A. The natural history of amyotrophic lateral sclerosis: observations with the Charing Cross ALS Severity Scales. In Munsat TL, Serratrice G, ed. Pathogenesis and Therapy of Amyotrophic lateral sclerosis. Advances in Neurology. Philadelphia: Lippincott-Raven Publishers, 1995:68;185-98
  • Goonetilleke A, Guiloff RJ. Motor Neuron Disease: Ethics, Outcome Variables and Clinical Scales. In Guiloff RJ, ed. Clinical Trials in Neurology. Springer-Verlag, 2000
  • Goonetilleke A, Harris JB. Neurological problems caused by envenoming bites and stings, and the consumption of poisonous seafood. In Blain PG & Harris JB, ed. Medical Neurotoxicology: occupational and environmental causes of neurological dysfunction, 1999: 111-125

Education & Training

  • MBBS
  • MRCP
  • FRCP (UK)

Membership

  • General Medical Council, UK
  • Royal College of Physicians, UK
  • Association of British Neurologists
  • American Academy of Neurology

Blogs